Ⅲ+Ⅳ期非小细胞肺癌调强放疗剂量学参数预测有症状放射性肺炎的临床研究.pdf

现代肿瘤医学2017年2月第25卷第4期 MODERN ONCOLOGY,Feb.2017,VOL.25,NO.04
].现代商贸工业,2016,2:212-213.]
leukemia molecular signature[ J]. Oncogene, 2003, 22(25): 3952
[2] Ii A, Niu FY, Han JF, et al. Predictive and prognostic value of de
novo MET expression in patients with advanced non-small-cell- [10] Sun D, Lu J, Ding K, et al. The
of Eg5 predicts a poor
lung cancer[ J]. Lung Cancer, 2015, 90(3): 375-380
outcome for patients with renal cell carcinoma [ J]. Med Oncol
13] Lu ZL, Ren WH, Jia WD, et al. The expression and significance of
2013,30(1):476
kinesin Fg5 in hepatocellular carcinoma [ J J Med University of [11] Chen JX. Expression of Egs and PCNA in human bladder
T cae no-
Anhui,2012,47(9):28-30.[卢正磊,任维华,斐卫东,等·驱
ma and its influence on the biological behavior of bladder cancer
动蛋白Eg5在肝细胞癌中的表达及其意义[J].安徽医科大学
[J]. J Med University of Anhui, 2014, 06(8): 743-753. [Z
学报,2012,47(9):28-30.]
勋.E、PCNA在人膀胱癌组织的表达及其对膀胱癌组织生
[4] Le Guellec R, Paris JF, Coutrier A, et al. Clonning by differential
物学行为的影响[].安徽医科大学学报,2014,06(8):743
screening of a xenopus CDNA that encodes a kinesin-related pro-
teint [J]. Mol Cell Biol, 1991, 11(6): 3395-3398
12] Sun L, Lu J, Niu Z. A potent chemotherapeutic strategy with Egs
[5] Kwok BH, Yang JG, Kapoor TM, et al. The rate of bipolar spindle
inhibitor against gemcitabine resistant bladder cancer[ J]. PLS
assembly depends on the microtubule -gliding velocity of the mitt
One,2015,10(12):0144484
ic kinesin Eg5[J]. Cur Biol, 2004, 14(19): 1783-175
I 13] Saijo T, Ishii G, Ochiai A, et al. Eg5 expression is closely correla
6] Castillo A, Justice MJ. The kinesin related motor protein, E5, is es
ted with the response of advaneed non-small cell lung cancer to
sential for maintenance of pre-implar
an-timitotic agents combined with platinum chemotherapy J
Biochem Biophys Res Commun, 2007, 357(3): 694-699
Lung Ca
ancer
54(2):217-225
[7] Castilo A, Morse HC, Go rey V et al Overexpression of E 5 [ 14] Liu X, Gong H, Huang K Oncogenic role of kinesin proteins and targe-
causes genomic instability and tumor formation in mice[J. Cancer
ting kinesin therapy [J]. Cancer Sci, 2013, 104(6): 651-656
Res,2007,67(21):10138-10147
I 15] Luo XY, Zhang M, Liu J. Progress of kinesin Eg5 inhibitors in
8 Iiu I, [iu X, Mare M, et al. Overexpression of E5 correlates with
cancer research[ J ] Chongging Med J, 2013, 42(26): 3172
high grade astrocytic neoplasm J]. J Neuro Oncol, 2016, 126(1)
3174.[罗兴燕,张梅,刘进.驱动蛋白E5抑制剂在肿瘤研究
7-80
中的进展[J].重庆医学,2013,42(26):3172-3174
[9] Nowicki MO, Pawlowski P, Fischer T, ct al. Chronic myelogenous
(编校:张西敷)
Ⅲ+V期非小细胞肺癌调强放疗剂量学参数预测有症状放射性肺炎的
临床研究
陈银,王晓萍,孙向东,华海清,张新良
Symptomatic radiation pneumonitis following intensity modulated radiotherapy for stage
Ill and V non -small cell lung cancer: Dose-volume histogram analysis
Chen Yin, Wang Xiaoping", Sun Xiangdong, Hua Haiqing Zhang Xinliang
De of Rait Dem ofme f A r e 1t H l of PLA Af l d Ning ni
sity of Chinese Medicine, Jiangsu Nanjing 210002, China
(Abstract) Objective: To determine lung dosimetric constraints that correlated with symptomatic radiation pneumo
nitis(=2 grade ) in stage Il and V non-small cell lung cancer patients treated with intensity modulated radiother
py(IMRT) .Methods: 53 NSCL